Immunization of chimpanzees with tumor antigen MUC1 mucin tandem repeat peptide elicits both helper and cytotoxic T-cell responses

Clinical Cancer Research

Volumn 5, Issue 7, 1999, Pages 1918-1924

  Barratt Boyes, Simon M ^a,c   Vlad, Anda ^a   Finn, Olivera J ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; KEYHOLE LIMPET HEMOCYANIN; MUC1 MUCIN PEPTIDE; MUCIN LIKE CARCINOMA ASSOCIATED ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ARTICLE; BREAST ADENOCARCINOMA; CANCER IMMUNOTHERAPY; CHIMPANZEE; COLON ADENOCARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NONHUMAN; OVARY ADENOCARCINOMA; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TANDEM REPEAT; VACCINE PRODUCTION;

ANIMALS; CA-15-3 ANTIGEN; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; IMMUNIZATION; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; LYMPH NODES; LYMPHOCYTE ACTIVATION; PAN TROGLODYTES; PEPTIDES; REPETITIVE SEQUENCES, AMINO ACID; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0032809534     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Gendler, S. J., Spicer, A. P., Lalani, E. N., Duhig, T., Peat, N., Burchell, J., Pemberton, L., Boshell, M., and Taylor-Papadimitriou, J. Structure and biology of a carcinoma-associated mucin, MUC1. Am. Rev. Respir. Dis., 144: S42-S47, 1991.
2. Barnd, D. L., Lan, M. S., Metzgar, R. S., and Finn, O. J. Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc. Natl. Acad. Sci. USA, 86: 7159-7163, 1989.
3. Ioannides, C. G., Fisk, B., Jerome, K. R., Irimura, T., Wharton, J. T., and Finn, O. J. Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides. J. Immunol., 151: 3693-3703, 1993.
4. Jerome, K. R., Barnd, D. L., Bendt, K. M., Boyer, C. M., Taylor-Papadimitriou, J., McKenzie, I. F., Bast, R. C., Jr., and Finn, O. J. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res., 51: 2908-2916, 1991.
5. Domenech, N., Henderson, R. A., and Finn, O. J. Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin. J. Immunol., 155: 4766-4774, 1995.
6. Kotera, Y., Fontenot, J. D., Pecher, G., Metzgar, R. S., and Finn, O. J. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients. Cancer Res., 54: 2856-2860, 1994.
7. Gourevitch, M. M., von Mensdorff-Pouilly, S., Litvinov, S. V., Kenemans, P., van Kamp, G. J., Verstraeten, A. A., and Hilgers, J. Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients. Br. J. Cancer, 72: 934-938, 1995.
8. Finn, O. J., Jerome, K. R., Henderson, R. A., Pecher, G., Domenech, N., Magarian-Blander, J., and Barratt-Boyes, S. M. MUC-1 epithelial tumor mucin-based immunity and cancer vaccines. Immunol. Rev., 145: 61-89, 1995.
9. Barratt-Boyes, S. M. Making the most of mucin: a novel target for tumor immunotherapy. Cancer Immunol. Immunother., 43: 142-151, 1996.
10. Hiltbold, E. M., Ciborowski, P., and Finn, O. J. Naturally processed class II epitope from the tumor antigen MUC1 primes human CD4+ T cells. Cancer Res., 58: 5066-5070, 1998.
11. Pecher, G., and Finn, O. J. Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected Epstein-Barr virus-immortalized autologous B cells. Proc. Natl. Acad. Sci. USA, 93: 1699-1704, 1996.
12. Skeiky, Y. A., Guderian, J. A., Benson, D. R., Bacelar, O., Carvalho, E. M., Kubin, M., Badaro, R., Trinchieri, G., and Reed, S. G. A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12. J. Exp. Med., 181: 1527-1537, 1995.
13. Probst, P., Skeiky, Y. A., Sleeves, M., Gervassi, A., Grabstein, K. H., and Reed, S. G. A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-α production and expression of B7-1 in human monocyte-derived antigen-presenting cells. Eur. J. Immunol., 27: 2634-2642, 1997.
14. Skeiky, Y. A. W., Kennedy, M., Kaufman, D., Borges, M. M., Guderian, J. A., Scholler, J. K., Ovendale, P. J., Picha, K. S., Morrissey, P. J., Grabstein, K. H., Campos-Neto, A., and Reed, S. G. LeIF. A recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile. J. Immunol., 161: 6171-6179, 1998.
15. Barratt-Boyes, S. M., Kao, H., and Finn, O. J. Chimpanzee dendritic cells derived in vitro from blood monocytes and pulsed with antigen elicit specific immune responses in vivo. J. Immunother., 21: 142-148, 1998.
16. Prussin, C., and Metcalfe, D. D. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J. Immunol. Methods, 188: 117-128, 1995.
17. Jerome, K. R., Domenech, N., and Finn, O. J. Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA. J. Immunol., 151: 1654-1662, 1993.
18. Agrawal, B., Reddish, M. A., and Longenecker, B. M. In vitro induction of MUC-1 peptide-specific type 1 T lymphocyte and cytotoxic T lymphocyte responses from healthy multiparous donors. J. Immunol., 157: 2089-2095, 1996.
19. Kern, F., Surel, I. P., Brock, C., Freistedt, B., Radtke, H., Scheffold, A., Blasczyk, R., Reinke, P., Schneider-Mergener, J., Radbruch, A., Walden, P., and Volk, H. D. T-cell epitope mapping by flow cytometry. Nat. Med., 4: 975-978, 1998.
20. Goydos, J. S., Elder, E., Whiteside, T. L., Finn, O. I., and Lotze, M. T. A Phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma. J. Surg. Res., 63: 298-304, 1996.
21. Zhang, S., Graeber, L. A., Helling, F., Ragupathi, G., Adluri, S., Lloyd, K. O., and Livingston, P. O. Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice. Cancer Res., 56: 3315-3319, 1996.
22. Gong, J., Chen, L., Chen, D., Kashiwaba, M., Manome, Y., Tanaka, T., and Kufe, D. Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells. Gene Ther., 4: 1023-1028, 1997.
23. Gong, J., Chen, D., Kashiwaba, M., Li, Y., Chen, L., Takeuchi, H., Qu, H., Rowse, G. J., Gendler, S. J., and Kufe, D. Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells. Proc. Natl. Acad. Sci. USA, 95: 6279-6283, 1998.
24. Apostolopoulos, V., Pietersz, G. A., Loveland, B. E., Sandrin, M. S., and McKenzie, I. F. Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses. Proc. Natl. Acad. Sci. USA, 92: 10128-10132, 1995.
25. Karanikas, V., Hwang, L. A., Pearson, J., Ong, C. S., Apostolopoulos, V., Vaughan, H., Xing, P. X., Jamieson, G., Pietersz, G., Tait, B., Broadbent, R., Thynne, G., and McKenzie, I. F. Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein. J. Clin. Invest., 100: 2783-2792, 1997.
26. Rowse, G. J., Tempero, R. M., VanLith, M. L., Hollingsworth, M. A., and Gendler, S. J. Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model. Cancer Res., 58: 315-321, 1998.